Red wine-based drug may help curb obesity, diabetes

08/18/2011 | Daily Mail (London), The

A study in Scientific Reports found that mice taking resveratrol-based SRT1720 drugs did not gain extra weight, had improved stamina and were protected from diabetes despite having a high-fat diet. The drug has also extended the life span of mice in the junk food group by up to 44%. The findings suggest that drugs based on resveratrol, commonly found in red wines, may address obesity, diabetes, heart disease and cancer, experts said.

View Full Article in:

Daily Mail (London), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ